Cellectis
CLLS
34 hedge funds and large institutions have $30.5M invested in Cellectis in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.
575% more call options, than puts
Call options by funds: $27K | Put options by funds: $4K
68% more capital invested
Capital invested by funds: $18.1M → $30.5M (+$12.3M)
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
10% more funds holding
Funds holding: 31 → 34 (+3)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
6.87% less ownership
Funds ownership: 20.66% → 13.79% (-6.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$201K |
| 2 |
Two Sigma Investments
New York
|
+$124K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.3K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$27.8K |
| 5 |
LPL Financial
San Diego,
California
|
+$20.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.73M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$824K |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
-$610K |
| 4 |
D.E. Shaw & Co
New York
|
-$74.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$39.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $1.02K | +$783 | +330 | New |
|
27
UBS Group
Zurich,
Switzerland
| $308 | -$9.34K | -3,935 | -98% |
|
28
JP Morgan Chase
New York
| $256 | -$11.7K | -4,940 | -98% |
|
29
Fidelity Investments
Boston,
Massachusetts
| $123 | +$95 | +40 | New |
|
30
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $95 | – | – | – |
|
|
FGAM
31
Financial Gravity Asset Management
Lakeway,
Texas
| $42 | +$24 | +10 | +100% |
|
|
EWA
32
EverSource Wealth Advisors
Birmingham,
Alabama
| $40 | – | – | – |
|
33
Bank of America
Charlotte,
North Carolina
| $6 | – | – | – |
|
|
34
Millennium Management
New York
| – | -$1.73M | -1,095,966 | Closed |
|
|
35
D.E. Shaw & Co
New York
| – | -$74.5K | -47,154 | Closed |
|
|
TWC
36
TD Waterhouse Canada
Toronto,
Ontario, Canada
| – | -$540 | -360 | Closed |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| – | -$175 | -111 | Closed |
|
38
Barclays
London,
United Kingdom
| – | -$44 | -28 | Closed |
|
|
CG
39
Cutler Group
San Francisco,
California
| – | +$475 | +200 | New |
|
CLLS Hedge Fund Activity: Q4 2023 in Review
34 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2023, worth a combined $30.5M — up 68% from $18.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CLLS positions and 6 closed out — a net gain of 3 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $201K. The largest seller was Millennium Management, exiting entirely with an estimated $1.73M sold.
- 34 institutional investors held Cellectis (CLLS) as of Q4 2023, up from 31 in Q3 2023.
- Funds reported $30.5M of Cellectis stock for Q4 2023, up 68% quarter-over-quarter.
- 9 funds opened new Cellectis positions in Q4 2023 and 6 closed out, a net change of +3 holders.
- The largest Cellectis buyer in Q4 2023 was Morgan Stanley, an estimated $201K added.
- The largest Cellectis seller in Q4 2023 was Millennium Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q4 2023.